Pap prevalence and cervical cancer prevention among Alaska Native women.
Pap prevalence and cervical cancer prevention among Alaska Native women.
复制标题
阿拉斯加原住民妇女中巴氏涂片的患病率和宫颈癌的预防。
DOI：
10.1080/073993399245566
复制
发表时间：
1999
期刊：
影响因子：
--
通讯作者：
Holck,P
中科院分区：
文献类型：
--
作者：
Lanier,AP;Kelly,JJ;Holck,P
阿拉斯加原住民妇女健康项目 (WHP) 的目标是确定以下内容： (1) 根据干预期间之前和干预期间图表审查的子宫颈抹片患病率； （2）对癌症和癌症筛查服务（重点是宫颈癌）的了解程度； （三）对现有健康维护服务的使用情况和满意度； (4) 干预后知识的提高和癌症筛查率的提高。对生活在安克雷奇的 481 名阿拉斯加原住民（爱斯基摩人、阿留申人、印第安人）妇女进行了随机抽样调查，了解她们对癌症危险因素（烟草使用、性传播疾病 (STD)、生殖问题）、癌症筛查检查（巴氏涂片检查、乳房自检 (BSE)、医疗服务提供者乳房检查、乳房 X 光检查）的了解，以及她们对医疗保健和医疗保健服务的态度。据记录，62% 的对照女性在研究开始前的 3 年内至少进行过一次巴氏涂片检查；然而，据记录，只有 9% 的人每年进行巴氏筛查。干预措施包括分发教育材料、对任何女性健康问题提供咨询、特别夜间诊所以及提醒（邮件/电话）预约巴氏涂片。干预期结束后，从最初的 481 名参与者中随机选出 200 名女性，进行了第二次访谈。还对 481 名参与者、130 名非参与者和 250 名随机选择的对照完成了图表审查。记录了巴氏筛查率、宫颈癌知识的提高以及对项目干预的高度满意度。
The goals of the Alaska Native Women's Health Project (WHP) were to determine the following: (1) Pap prevalence based on chart review before and during an intervention period; (2) the level of understanding of cancer and cancer screening services with emphasis on cervical cancer; (3) use and satisfaction with current health maintenance services; and (4) improvement in knowledge and cancer screening rates following intervention. A random sample of 481 Alaska Native (Eskimo, Aleut, Indian) women living in Anchorage were interviewed face to face about their understanding of cancer risk factors (tobacco use, sexually transmitted diseases (STDs), reproductive issues), cancer screening examinations (Pap test, breast self-examination (BSE), breast exam by a provider, mammography), and their attitudes about health care and health care services. Sixty-two percent of control women were documented to have had at least one Pap test within the 3-year period prior to the beginning of the study; however, only 9% were documented to have had annual Pap screening. The intervention included distribution of educational materials, counseling on any woman's health issue, special evening clinics, and reminders (mail/phone call) of scheduled Pap appointments. A second interview was conducted after the intervention period among 200 women randomly selected from the original 481 participants. Chart reviews were also completed for the 481 participants, 130 nonparticipants, and 250 randomly selected controls. Improvement in Pap screening rates, knowledge of cervical cancer, and a high level of satisfaction with the project intervention was documented.